Business ExpansionSpecialty testing expansion in areas like oncology, neurology, autoimmune, and women's health is expected to help achieve higher long-term targets.
Financial PerformanceFree cash flow year-to-date totaled approximately +28.1% higher than 2023 ytd figures, a key highlight.
Management And StrategyManagement's progress in integrating Invitae is encouraging, with it being on track to be slightly accretive in the future.